UNJHA FORMULATIONS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Unjha Formulations along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.5₹ -0.12
As on Oct 31, 2025, 4:01 PM IST
Unjha Formulations Price Performance
Today's LowToday's High
₹24.00₹24.70
₹24.00
52 Weeks' Low52 Weeks' High
₹19.99₹39.00
₹24.00
Open Price
₹24.05
Prev. Close
₹24.12
Volume
240
Over the last 5 years, the share price of Unjha Formulations has gained 26.19% CAGR. Over the past year, the corresponding return has been -20.16%.
Unjha Formulations’s current P/E of 111.11x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Unjha Formulations Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Unjha Formulations | 1.78 | -3.85 | -4.46 | 0.59 | -24.67 | 34.16 | 26.19 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | 3.73 | -7.6 | -9.08 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 6.34 | 10.85 | 14.59 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | 0.03 | -1.58 | -3.69 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.8 | -0.38 | -3.39 | 9.01 | 10.66 | 29.1 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -1.68 | 1.37 | -4.72 | 10.6 | 4.3 |
| Mankind Pharma | -2.15 | -2.43 | -7.14 | -0.11 | -11.57 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 2.64 | 10 | -2.99 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 5.56 | -4.31 | -10.42 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | 5.46 | -6.06 | -18.73 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 12.48 | 8.53 | -5.2 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -13.89 | -5.7 | -1.05 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -8.54 | 37.43 | 11.8 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 12.55 | 53.86 | 91.09 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -2.86 | 16.74 | 17.02 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -10.55 | -8 | -3.86 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -3.73 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -12.53 | -7.87 | -21.04 | 11.98 | 2 |
| Gland Pharma | -0.6 | -2.66 | -2.59 | 37.25 | 17.21 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -8.44 | -4.54 | -19.88 | 23.86 | 18.63 |
Over the last one year, Unjha Formulations has declined 24.67% compared to peers like Sun Pharmaceutical Industries (-9.08%), Divi's Laboratories (14.59%), Cipla (-3.69%). From a 5 year perspective, Unjha Formulations has outperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
Unjha Formulations Financials
Unjha Formulations Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 24.04 | 24.07 |
| 10 | 24.27 | 24.16 |
| 20 | 24.54 | 24.37 |
| 50 | 24.83 | 24.57 |
| 100 | 24.43 | 24.58 |
| 200 | 24.57 | 24.74 |
Unjha Formulations Share Holding Pattern
In the latest quarter, Unjha Formulations remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding unchanged at 63.08% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Unjha Formulations Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 29, 2025, 9:35 PM IST | Unjha Formulatio - Board Meeting Intimation for Board Meeting - Date: 10.11.2025 (Un-Audited Financial Results For The Half Y |
| Oct 10, 2025, 10:42 PM IST | Unjha Formulatio - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 01, 2025, 9:38 PM IST | Unjha Formulatio - Board Meeting Outcome for Outcome Of Board Meeting - Appointment Of Company Secretary AndCompliance Of |
| Sep 05, 2025, 8:10 PM IST | Unjha Formulatio - Submissions Of XML File For Financial Statement I.E. Balance Sheet , P&L Accounts And Cash Flow Statement |
| Aug 14, 2025, 12:42 AM IST | Unjha Formulatio - Filing Of Distribution Schedule |
About Unjha Formulations
Unjha Formulations Ltd. is a Public Limited Listed company incorporated on 02/09/1994 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L99999GJ1994PLC022932 and registration number is 022932. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 13.86 Cr. and Equity Capital is Rs. 4.48 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressKhali Char Rasta, State Highway Sidhpur Gujarat 384151
- Contact
Management
- Mrs. Jashodaben S PatelChairman
- Mrs. Krutiben M PatelManaging Director
- Ms. Esha M PatelDirector
- Mr. Hashmukh S DarjiDirector
- Mr. Jitendra P LambachiyaDirector
- Mr. Mustufa Najamuddin JodhpurwalaDirector
FAQs on Unjha Formulations Share Price
What is the share price of Unjha Formulations?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Unjha Formulations is ₹24.00 as on Oct 31, 2025.
What kind of stock is Unjha Formulations?
The Unjha Formulations is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Unjha Formulations?
The market cap of Unjha Formulations is ₹10.75 Cr as on Oct 31, 2025.
What are today's High and Low prices of Unjha Formulations?
Today’s highest and lowest price of Unjha Formulations are ₹24.70 and ₹24.00.
What are the 52 Week High and 52 Week Low of Unjha Formulations?
The 52-week high/low is the highest and lowest price at which Unjha Formulations stock has traded in the past 52-week or nearly a year. The 52-week high of Unjha Formulations is ₹39.00 and 52-week low of Unjha Formulations is ₹19.99 as on Oct 31, 2025.
How has the Unjha Formulations performed historically in terms of returns?
The Unjha Formulations has shown returns of -0.5% over the past day, -3.85% for the past month, -7.34% over 3 months, -20.16% over 1 year, 34.16% across 3 years, and 26.19% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Unjha Formulations?
P/E ratio of and PB ratio of Unjha Formulations are 111.11 and 3.43 on Oct 31, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse